Insider Transactions
Date | Filing | Filer | Title | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 15, 2024 | Form 4 |
EVP and CFO
|
EVP and CFO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,143 | -- | 74,735 |
Feb 15, 2024 | Form 4 |
EVP and CFO
|
EVP and CFO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,388 | -- | 9,122 |
Feb 07, 2023 | Form 4 |
EVP and CFO
|
EVP and CFO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 26,068 | -- | 49,681 |
Feb 15, 2024 | Form 4 |
EVP and CFO
|
EVP and CFO | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 12,811 | $63.42 | 61,924 |
Jan 29, 2021 | Form 4 |
EVP and CFO
|
EVP and CFO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,591 | -- | 10,591 |
Feb 07, 2023 | Form 4 |
EVP and CFO
|
EVP and CFO | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 9,824 | $66.78 | 39,857 |
Feb 09, 2021 | Form 4 |
EVP and CFO
|
EVP and CFO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,325 | -- | 19,115 |
Feb 09, 2024 | Form 4 |
EVP and CFO
|
EVP and CFO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,108 | -- | 6,108 |
Feb 10, 2020 | Form 4 |
EVP and CFO
|
EVP and CFO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,040 | -- | 14,124 |
Feb 09, 2023 | Form 4 |
EVP and CFO
|
EVP and CFO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,035 | -- | 5,035 |
Data provided by Kaleidoscope.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.